Rs2070235, which results in a missense variant (Ser > Gly) of MYBL2 protein, was reported to be associated with an increased risk of breast cancer (39), but not with the incidence of acute myeloid leukemia (63). This evidence concerns the gene MYBL2 and breast cancer.